Pulmofor retard, capsules

7680499260227 CH-49926 Kapseln

Associated product:

PULMOFOR retard caps ret 10 pce
Pulmofor retard, capsules
Pulmofor retard, capsules
Pulmofor retard, capsules
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/11/2022
Summary of Product Characteristics
Français
08/11/2022
Summary of Product Characteristics
Italien
08/11/2022
Patient information leaflet
Allemand
07/11/2022
Patient information leaflet
Français
07/11/2022
Patient information leaflet
Italien
07/11/2022

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance WIZUS
(N/A)
36.6 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
58.6 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
49926
Drug name
Pulmofor retard, capsules
Galenic form
RETH
ATC Code
R05DA09
Authorization status
Z
Dispensing category
B
First authorization
10/02/1995
Authorization expiration date
31/12/9999
IT Number
03.01.1.
Domain
Human medicine
Field of application
Husten, insbesondere Reizhusten

Package details

Description (FR)
PULMOFOR retard caps ret 10 pce
Description (DE)
PULMOFOR retard Ret Kaps 10 Stk
Market launch
10/02/1995
Narcotic (BTM)
No